File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.atherosclerosis.2023.117246
- Scopus: eid_2-s2.0-85169562042
- WOS: WOS:001070582300001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study
Title | Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study |
---|---|
Authors | |
Keywords | 3-Hydroxyisobutyrate Branch-chain amino acids Diabetes Ischemic heart disease Mendelian randomization Sex-specific |
Issue Date | 20-Aug-2023 |
Publisher | Elsevier |
Citation | Atherosclerosis, 2023, v. 381 How to Cite? |
Abstract | Background and aims: Branch-chain amino acids (BCAAs) are linked to higher risk of diabetes, whilst the evidence on ischemic heart disease (IHD) is limited. Valine metabolite, 3-hydroxyisobutyrate (3-HIB), also plays an important role in metabolism, whilst its effect has been rarely examined. At the situation of no evidence from large trials, we assessed the role of BCAAs and 3-HIB in IHD and diabetes using Mendelian randomization to minimize confounding. Given their potential role in sex hormones, we also examined sex-specific associations. Methods: We used genetic variants to predict BCAAs and 3-HIB, and obtained their associations with IHD and diabetes in large consortia and cohorts, as well as sex-specific association in the UK Biobank and DIAGRAM. We obtained and combined the Wald estimates using inverse variance weighting, and different analytic methods robust to pleiotropy. Results: Genetically predicted BCAAs were associated with higher risk of IHD (odds ratio (OR) 1.19 per standard deviation (SD) increase in BCAAs, 95% confidence interval (CI) 1.05 to 1.35) and diabetes (OR 1.20, 95% CI 1.08 to 1.34). The associations with IHD were stronger in women (OR 1.23, 95% CI 1.03 to 1.48) than men (OR 0.96, 95% CI 0.83 to 1.10). 3-HIB was associated with higher risk of IHD (OR 1.43, 95% CI 1.17 to 1.73) but not diabetes, with no sex disparity. Conclusion: BCAAs and 3-HIB are potential targets for prevention in IHD and/or diabetes. BCAAs may exert a sex-specific role in IHD. Consideration of the sex disparity and exploration of the underlying pathways would be worthwhile. Keywords: 3-Hydroxyisobutyrate; Branch-chain amino acids; Diabetes; Ischemic heart disease; Mendelian randomization; Sex-specific. |
Persistent Identifier | http://hdl.handle.net/10722/331692 |
ISSN | 2023 Impact Factor: 4.9 2023 SCImago Journal Rankings: 1.461 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhao, Jie V | - |
dc.contributor.author | Fan, Bohan | - |
dc.contributor.author | Burgess, Stephen | - |
dc.date.accessioned | 2023-09-21T06:58:03Z | - |
dc.date.available | 2023-09-21T06:58:03Z | - |
dc.date.issued | 2023-08-20 | - |
dc.identifier.citation | Atherosclerosis, 2023, v. 381 | - |
dc.identifier.issn | 0021-9150 | - |
dc.identifier.uri | http://hdl.handle.net/10722/331692 | - |
dc.description.abstract | <p><strong>Background and aims: </strong>Branch-chain amino acids (BCAAs) are linked to higher risk of diabetes, whilst the evidence on ischemic heart disease (IHD) is limited. Valine metabolite, 3-hydroxyisobutyrate (3-HIB), also plays an important role in metabolism, whilst its effect has been rarely examined. At the situation of no evidence from large trials, we assessed the role of BCAAs and 3-HIB in IHD and diabetes using Mendelian randomization to minimize confounding. Given their potential role in sex hormones, we also examined sex-specific associations.</p><p><strong>Methods: </strong>We used genetic variants to predict BCAAs and 3-HIB, and obtained their associations with IHD and diabetes in large consortia and cohorts, as well as sex-specific association in the UK Biobank and DIAGRAM. We obtained and combined the Wald estimates using inverse variance weighting, and different analytic methods robust to pleiotropy.</p><p><strong>Results: </strong>Genetically predicted BCAAs were associated with higher risk of IHD (odds ratio (OR) 1.19 per standard deviation (SD) increase in BCAAs, 95% confidence interval (CI) 1.05 to 1.35) and diabetes (OR 1.20, 95% CI 1.08 to 1.34). The associations with IHD were stronger in women (OR 1.23, 95% CI 1.03 to 1.48) than men (OR 0.96, 95% CI 0.83 to 1.10). 3-HIB was associated with higher risk of IHD (OR 1.43, 95% CI 1.17 to 1.73) but not diabetes, with no sex disparity.</p><p><strong>Conclusion: </strong>BCAAs and 3-HIB are potential targets for prevention in IHD and/or diabetes. BCAAs may exert a sex-specific role in IHD. Consideration of the sex disparity and exploration of the underlying pathways would be worthwhile.</p><p><strong>Keywords: </strong>3-Hydroxyisobutyrate; Branch-chain amino acids; Diabetes; Ischemic heart disease; Mendelian randomization; Sex-specific.</p> | - |
dc.language | eng | - |
dc.publisher | Elsevier | - |
dc.relation.ispartof | Atherosclerosis | - |
dc.subject | 3-Hydroxyisobutyrate | - |
dc.subject | Branch-chain amino acids | - |
dc.subject | Diabetes | - |
dc.subject | Ischemic heart disease | - |
dc.subject | Mendelian randomization | - |
dc.subject | Sex-specific | - |
dc.title | Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.atherosclerosis.2023.117246 | - |
dc.identifier.scopus | eid_2-s2.0-85169562042 | - |
dc.identifier.volume | 381 | - |
dc.identifier.isi | WOS:001070582300001 | - |
dc.identifier.issnl | 0021-9150 | - |